Icatibant acetate

Description

Icatibant acetate · CAS 138614-30-9 · C61H93N19O15S. UNII 325O8467XK.

Identification

Computed Descriptors

Documented Uses

• Breast Feeding; Lactation; Milk, Human; Bradykinin Receptor Antagonists; Bradykinin B2 Receptor Antagonists
• Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
• Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ B2 RECEPTORS.
• Bradykinin B2 Receptor Antagonist [EPC]; Bradykinin B2 Receptor Antagonists [MoA]

Synonyms

Icatibant acetate; 138614-30-9; Hoe-140; HOE 140; 325O8467XK; Hoechst 140; Hoechst-140; SAJAZIR; JE049; RefChem:57035; DTXSID201027613; 863-000-7; CHEBI:68564; Icatibant (acetate); Icatibant acetate [USAN]; Firazyr

Frequently Asked Questions

What are the CAS number and molecular formula of Icatibant acetate?

CAS 138614-30-9; molecular formula C61H93N19O15S; molecular weight — g/mol.

What other names is Icatibant acetate known by?

Icatibant acetate, 138614-30-9, Hoe-140, HOE 140, 325O8467XK, Hoechst 140.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.